(Q48165414)

9 February 2018

title

Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia (English)

1 reference

9 February 2018

0 references

0 references

3

1 reference

9 February 2018

Anders Bue Klein

4

1 reference

9 February 2018

Gitte Moos Knudsen

5

1 reference

9 February 2018

Cecilia Ratner

object named as

Cecilia Ratner

2

0 references

Jens Damsgaard Mikkelsen

6

object named as

Jens D Mikkelsen

1 reference

9 February 2018

author name string

Martin A Santini

1

1 reference

9 February 2018

publication date

13 February 2013

1 reference

9 February 2018

Journal of Neuroscience Research

number of pages

8

0 references

published in

1 reference

9 February 2018

volume

91

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

634-641

1 reference

9 February 2018

PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors

cites work

1 reference

Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats

21 January 2018

1 reference

Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability

21 January 2018

1 reference

The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis

21 January 2018

1 reference

The immediate early gene arc/arg3.1: regulation, mechanisms, and function.

21 January 2018

1 reference

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

21 January 2018

1 reference

Glutamate and schizophrenia: beyond the dopamine hypothesis

21 January 2018

1 reference

Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice

21 January 2018

1 reference

Serotonin 2A receptor antagonists for treatment of schizophrenia

21 January 2018

1 reference

Psychedelics and schizophrenia

21 January 2018

1 reference

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior

21 January 2018

1 reference

Identification of a serotonin/glutamate receptor complex implicated in psychosis

21 January 2018

1 reference

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

21 January 2018

1 reference

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

21 January 2018

1 reference

Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function

21 January 2018

1 reference

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.

21 January 2018

1 reference

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring

21 January 2018

1 reference

Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex.

21 January 2018

1 reference

Decreased Frontal Serotonin2A Receptor Binding in Antipsychotic-Naive Patients With First-Episode Schizophrenia

21 January 2018

1 reference

Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo

21 January 2018

1 reference

Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.

21 January 2018

1 reference

MS-377, a novel selective sigma(1) receptor ligand, reverses phencyclidine-induced release of dopamine and serotonin in rat brain

21 January 2018

1 reference

alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment

21 January 2018

1 reference

α7 Nicotinic receptor agonism mitigates phencyclidine-induced changes in synaptophysin and Arc gene expression in the mouse prefrontal cortex

21 January 2018

1 reference

Opposite effect of phencyclidine on activity-regulated cytoskeleton-associated protein (Arc) in juvenile and adult limbic rat brain regions

21 January 2018

1 reference

Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists

21 January 2018

1 reference

Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia

21 January 2018

1 reference

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

21 January 2018

1 reference

Chandelier cells control excessive cortical excitation: characteristics of whisker-evoked synaptic responses of layer 2/3 nonpyramidal and pyramidal neurons.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.23198

1 reference

9 February 2018

1 reference

9 February 2018